Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva
Essential Pharma acquires European rights to Colobreathe®(colistimethate sodium) from Teva Colobreathe® is an inhaled antibiotic
January 8, 2024
Day: January 8, 2024
(EDITORIAL from Korea Herald on Jan. 8)
Instigation of conflict within the South has always been the North’s key strategy
South
January 8, 2024
Seoul city weighs increasing subway base fare by 150 won in July
SEOUL, The Seoul city government said Monday it is considering increasing the base fare
January 8, 2024
(LEAD) FM nominee vows to accelerate S. Korea-U.S.-Japan cooperation amid growing N.K. threats
SEOUL, South Korea’s foreign minister nominee vowed Monday to focus on accelerating cooperation with
January 8, 2024
Celltrion to cancel about 1 pct of outstanding shares
SEOUL, Celltrion Inc., a South Korean pharmaceutical company, said Monday it has begun the
January 8, 2024
S. Korean military reaffirms N. Korea’s Jan. 6 firing drills
SEOUL, The South Korean military on Monday reaffirmed that North Korea conducted live-fire drills
January 8, 2024